Albumin Attachment Can Make Better Biobetters
Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.
Albumin, the most prevalent protein found in blood plasma, is an emerging drug-delivery tool that has been found to be versatile and effective. Albumins can be used in drug formulation because they have been shown to stabilize and extend the shelf-life of the end product. Furthermore, albumins, both naturally occurring and engineered, can be used to extend the half-life of a drug.
Read this article from in Pharmaceutical Technology’s Biologics and Sterile Drug Manufacturing 2018 eBook.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing
Vol. 42
May 2018
Pages: 8–12
Citation
When referring to this article, please cite it as F. Mirasol, "Albumin Attachment Can Make Better Biobetters," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2018).
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
